Cambridge spin-out secures £18m to tackle Alzheimer’s and related diseases
A biopharmaceutical company set-up by Cambridge academics from St John’s College to develop drugs to treat illnesses such as Alzheimer’s, Parkinson’s and more than 50 other related diseases has won £18 million in
Read More